Literature DB >> 20730558

Palmitoyl ascorbate-loaded polymeric micelles: cancer cell targeting and cytotoxicity.

Rupa R Sawant1, Onkar Vaze, Gerard G M D'Souza, Karen Rockwell, Vladimir P Torchilin.   

Abstract

PURPOSE: To evaluate the potential of palmitoyl ascorbate (PA)-loaded micelles for ascorbate-mediated cancer cell targeting and cytotoxicity.
METHODS: PA was incorporated in polyethylene glycol-phosphatidyl ethanolamine micelles at varying concentrations. The formulations were evaluated for PA content by RP-HPLC. A stable formulation was selected based on size and zeta potential measurements. A co-culture of cancer cells and GFP-expressing non-cancer cells was used to determine the specificity of PA micelle binding. In vitro cytotoxicity of the micellar formulations towards various cancer cell lines was investigated using a cell viability assay. To elucidate the mechanism of action of cell death in vitro, the effect of various H(2)O(2) scavengers and metal chelators on PA-mediated cytotoxicity was studied. The in vivo anti-cancer activity of PA micelles was studied in female Balb/c mice bearing a murine mammary carcinoma (4T1 cells).
RESULTS: PA micelles associated preferentially with various cancer cells compared to non-cancer cells in co-culture. PA micelles exhibited anti-cancer activity in cancer cell lines both in vitro and in vivo. The mechanism of cell death was due primarily to generation of reactive oxygen species (ROS).
CONCLUSIONS: The anti-cancer activity of PA micelles associated with its enhanced cancer cell binding and subsequent generation of ROS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20730558     DOI: 10.1007/s11095-010-0242-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  45 in total

1.  Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid.

Authors:  S C Rumsey; O Kwon; G W Xu; C F Burant; I Simpson; M Levine
Journal:  J Biol Chem       Date:  1997-07-25       Impact factor: 5.157

2.  The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells.

Authors:  M Sattler; S Verma; G Shrikhande; C H Byrne; Y B Pride; T Winkler; E A Greenfield; R Salgia; J D Griffin
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

3.  Effect of colloidal carriers on ascorbyl palmitate stability.

Authors:  Julijana Kristl; Breda Volk; Mirjana Gasperlin; Marjeta Sentjurc; Polona Jurkovic
Journal:  Eur J Pharm Sci       Date:  2003-07       Impact factor: 4.384

Review 4.  Lipid-core micelles for targeted drug delivery.

Authors:  Vladimir P Torchilin
Journal:  Curr Drug Deliv       Date:  2005-10       Impact factor: 2.565

5.  Stromal cell oxidation: a mechanism by which tumors obtain vitamin C.

Authors:  D B Agus; J C Vera; D W Golde
Journal:  Cancer Res       Date:  1999-09-15       Impact factor: 12.701

Review 6.  Antioxidant enzyme levels in cancer.

Authors:  T D Oberley; L W Oberley
Journal:  Histol Histopathol       Date:  1997-04       Impact factor: 2.303

7.  Investigation of the role of extracellular H2O2 and transition metal ions in the genotoxic action of ascorbic acid in cell culture models.

Authors:  Tiago L Duarte; Gabriela M Almeida; George D D Jones
Journal:  Toxicol Lett       Date:  2007-02-20       Impact factor: 4.372

8.  PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing.

Authors:  Z Gao; A N Lukyanov; A R Chakilam; V P Torchilin
Journal:  J Drug Target       Date:  2003-02       Impact factor: 5.121

9.  Effect of Ascorbic Acid and Its Hydrophobic Derivative Palmitoyl Ascorbate on the Redox State of Primary Human Fibroblasts.

Authors:  Gennady Rosenblat; Martin F. Graham; Adi Jonas; Mark Tarshis; Shay Yehoshua Schubert; Mina Tabak; Ishak Neeman
Journal:  J Med Food       Date:  2001       Impact factor: 2.786

10.  Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo.

Authors:  Qi Chen; Michael Graham Espey; Andrew Y Sun; Je-Hyuk Lee; Murali C Krishna; Emily Shacter; Peter L Choyke; Chaya Pooput; Kenneth L Kirk; Garry R Buettner; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

View more
  7 in total

1.  Preparation and characterization of galactosylated glycol chitosan micelles and its potential use for hepatoma-targeting delivery of doxorubicin.

Authors:  Jing-Mou Yu; Wei-Dong Li; Lu Lu; Xue-Yun Zhou; Dian-Yuan Wang; Hui-Min Li; Xiao-Yuan Xu; Jian Chen
Journal:  J Mater Sci Mater Med       Date:  2013-12-14       Impact factor: 3.896

2.  Co-delivery of docetaxel and palmitoyl ascorbate by liposome for enhanced synergistic antitumor efficacy.

Authors:  Junxiu Li; Chaorui Guo; Fan Feng; Ali Fan; Yu Dai; Ning Li; Di Zhao; Xijing Chen; Yang Lu
Journal:  Sci Rep       Date:  2016-12-09       Impact factor: 4.379

3.  Ascorbyl stearate stimulates cell death by oxidative stress-mediated apoptosis and autophagy in HeLa cervical cancer cell line in vitro.

Authors:  Shirish Dinkar Mane; Akhilender Naidu Kamatham
Journal:  3 Biotech       Date:  2019-03-02       Impact factor: 2.406

4.  Synthesis and In Vitro Characterization of Ascorbyl Palmitate-Loaded Solid Lipid Nanoparticles.

Authors:  Maja Ledinski; Ivan Marić; Petra Peharec Štefanić; Iva Ladan; Katarina Caput Mihalić; Tanja Jurkin; Marijan Gotić; Inga Urlić
Journal:  Polymers (Basel)       Date:  2022-04-26       Impact factor: 4.967

5.  Drug nanoparticle formulation using ascorbic Acid derivatives.

Authors:  Kunikazu Moribe; Waree Limwikrant; Kenjirou Higashi; Keiji Yamamoto
Journal:  J Drug Deliv       Date:  2011-04-26

6.  Dual-responsive, Methotrexate-loaded, Ascorbic acid-derived Micelles Exert Anti-tumor and Anti-metastatic Effects by Inhibiting NF-κB Signaling in an Orthotopic Mouse Model of Human Choriocarcinoma.

Authors:  Lili Wei; Chenyuan Wang; Xianjue Chen; Bing Yang; Kun Shi; Leah R Benington; Lee Yong Lim; Sanjun Shi; Jingxin Mo
Journal:  Theranostics       Date:  2019-06-09       Impact factor: 11.556

7.  Ascorbyl palmitate-incorporated paclitaxel-loaded composite nanoparticles for synergistic anti-tumoral therapy.

Authors:  Min Zhou; Xin Li; Yuanyuan Li; Qiu'e Yao; Yue Ming; Ziwei Li; Laichun Lu; Sanjun Shi
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.